Literature DB >> 24497587

Socio-Economic Status and Peritonitis in Australian Non-Indigenous Peritoneal Dialysis Patients.

Wen Tang1, Blair Grace2, Stephen P McDonald3, Carmel M Hawley4, Sunil V Badve4, Neil C Boudville5, Fiona G Brown6, Philip A Clayton7, David W Johnson8.   

Abstract

UNLABELLED: ♦
BACKGROUND: The aim of the present study was to investigate the relationship between socio-economic status (SES) and peritoneal dialysis (PD)-related peritonitis. ♦
METHODS: Associations between area SES and peritonitis risk and outcomes were examined in all non-indigenous patients who received PD in Australia between 1 October 2003 and 31 December 2010 (peritonitis outcomes). SES was assessed by deciles of postcode-based Australian Socio-Economic Indexes for Areas (SEIFA), including Index of Relative Socio-economic Disadvantage (IRSD), Index of Relative Socio-economic Advantage and Disadvantage (IRSAD), Index of Economic Resources (IER) and Index of Education and Occupation (IEO). ♦
RESULTS: 7,417 patients were included in the present study. Mixed-effects Poisson regression demonstrated that incident rate ratios for peritonitis were generally lower in the higher SEIFA-based deciles compared with the reference (decile 1), although the reductions were only statistically significant in some deciles (IRSAD deciles 2 and 4 - 9; IRSD deciles 4 - 6; IER deciles 4 and 6; IEO deciles 3 and 6). Mixed-effects logistic regression showed that lower probabilities of hospitalization were predicted by relatively higher SES, and lower probabilities of peritonitis-associated death were predicted by less SES disadvantage status and greater access to economic resources. No association was observed between SES and the risks of peritonitis cure, catheter removal and permanent hemodialysis (HD) transfer. ♦
CONCLUSIONS: In Australia, where there is universal free healthcare, higher SES was associated with lower risks of peritonitis-associated hospitalization and death, and a lower risk of peritonitis in some categories.
Copyright © 2015 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  Peritoneal dialysis; education; income; mortality; outcomes; peritonitis; socio-economical status

Mesh:

Year:  2014        PMID: 24497587      PMCID: PMC4520728          DOI: 10.3747/pdi.2013.00004

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  25 in total

1.  Peritoneal dialysis-related infections recommendations: 2010 update.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Judith Bernardini; Ana E Figueiredo; Amit Gupta; David W Johnson; Ed J Kuijper; Wai-Choong Lye; William Salzer; Franz Schaefer; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2010 Jul-Aug       Impact factor: 1.756

2.  Performance of a mixed effects logistic regression model for binary outcomes with unequal cluster size.

Authors:  Moonseong Heo; Andrew C Leon
Journal:  J Biopharm Stat       Date:  2005       Impact factor: 1.051

Review 3.  ISPD position statement on reducing the risks of peritoneal dialysis-related infections.

Authors:  Beth Piraino; Judith Bernardini; Edwina Brown; Ana Figueiredo; David W Johnson; Wai-Choong Lye; Valerie Price; Santhanam Ramalakshmi; Cheuk-Chun Szeto
Journal:  Perit Dial Int       Date:  2011-08-31       Impact factor: 1.756

4.  Dialysis in public and private hospitals in Queensland.

Authors:  N A Gray; H Dent; S P McDonald
Journal:  Intern Med J       Date:  2012-08       Impact factor: 2.048

5.  Recent peritonitis associates with mortality among patients treated with peritoneal dialysis.

Authors:  Neil Boudville; Anna Kemp; Philip Clayton; Wai Lim; Sunil V Badve; Carmel M Hawley; Stephen P McDonald; Kathryn J Wiggins; Kym M Bannister; Fiona G Brown; David W Johnson
Journal:  J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 10.121

6.  Social deprivation and survival on renal replacement therapy in England and Wales.

Authors:  F J Caskey; P Roderick; R Steenkamp; D Nitsch; K Thomas; D Ansell; T Feest
Journal:  Kidney Int       Date:  2006-10-25       Impact factor: 10.612

7.  Patient and physician predictors of peritoneal dialysis technique failure: a population based, retrospective cohort study.

Authors:  Mala Chidambaram; Joanne M Bargman; Robert R Quinn; Peter C Austin; Janet E Hux; Andreas Laupacis
Journal:  Perit Dial Int       Date:  2010-10-14       Impact factor: 1.756

8.  Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations.

Authors:  Stephen P McDonald; John F Collins; Markus Rumpsfeld; David W Johnson
Journal:  Perit Dial Int       Date:  2004 Jul-Aug       Impact factor: 1.756

9.  The inverse care law revisited: impact of disadvantaged location on accessing longer GP consultation times.

Authors:  John S Furler; Elizabeth Harris; Patty Chondros; P Gawaine Powell Davies; Mark F Harris; Doris Y L Young
Journal:  Med J Aust       Date:  2002-07-15       Impact factor: 7.738

10.  Dialysis outcomes in Colombia (DOC) study: a comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia.

Authors:  M Sanabria; J Muñoz; C Trillos; G Hernández; C Latorre; C S Díaz; S Murad; K Rodríguez; A Rivera; A Amador; F Ardila; A Caicedo; D Camargo; A Díaz; J González; H Leguizamón; P Lopera; L Marín; I Nieto; E Vargas
Journal:  Kidney Int Suppl       Date:  2008-04       Impact factor: 10.545

View more
  2 in total

1.  The Association of Individual and Regional Socioeconomic Status on Initial Peritonitis and Outcomes in Peritoneal Dialysis Patients: A Propensity Score-Matched Cohort Study.

Authors:  Qin Wang; Ke-Jie Hu; Ye-Ping Ren; Jie Dong; Qing-Feng Han; Tong-Ying Zhu; Jiang-Hua Chen; Hui-Ping Zhao; Meng-Hua Chen; Rong Xu; Yue Wang; Chuan-Ming Hao; Xiao-Hui Zhang; Mei Wang; Na Tian; Hai-Yan Wang
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

2.  Peritoneal dialysis in rural Australia.

Authors:  Nicholas A Gray; Blair S Grace; Stephen P McDonald
Journal:  BMC Nephrol       Date:  2013-12-20       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.